Apricus Biosciences Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Apricus Biosciences

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: mokelumne river	5/3/2016 2:52:50 PM
	Read Replies (1) of 2026

So I was ready to go off the reservation this morning. I noticed that the press release stated that the Vitaros NDA would be resubmitted in 2H16, whereas the corporate presentation and the April 6 update both state clearly that the NDA would be resubmitted in Q3 without qualification. So I penned a flaming post and then did what I used to counsel my engineering staff to do when I had a day job. I calmed down and did not hit the send button. Instead I emailed a civil note to Matt Beck asking for clarification. His response: Good catch James. We just issued a corrected press release to change 2H to 3Q; we confirm we’re on track for Q3 re-submission. Matt Beck I am a much happier camper and am pleased that Matt got right back to me.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next